Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,744 total, page 19 of 35

COMPLETED NA

Designing Food Voucher Programs to Reduce Disparities in Healthy Diets

NCT02843178

TERMINATED NA

Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer

NCT03049358

COMPLETED Phase 1

A Pilot Study of Vitamin D in Boys With X-linked Adrenoleukodystrophy

NCT02595489

COMPLETED NA

Infrared and Broadband Light for Skin Aging

NCT03243981

COMPLETED NA

Enhancing Community Capacity to Improve Cancer Care Delivery

NCT04107116

TERMINATED Phase 1

Neuroimaging GABA Physiology in Fragile X Syndrome

NCT04308954

COMPLETED Phase 1

The Stanford Parkinson's Disease Plasma Study

NCT02968433

COMPLETED Phase 3

Labor and Delivery Implant Insertion: A Randomized Controlled Trial

NCT02866643

COMPLETED NA

Detecting Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring (CGM)

NCT03032523

COMPLETED Phase 4

Tissue Sealant Use in LASIK Enhancement Surgery

NCT02952365

COMPLETED NA

Initiate and Maintain Physical Activity in Clinics: The IMPACT Diabetes Study

NCT02061579

COMPLETED NA

The EARN-Health Trial of Financial Savings and Health

NCT02185612

COMPLETED Phase 2

Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis

NCT02663895

COMPLETED NA

Feasibility of Home-based Virtual Reality Rehabilitation for the Upper Extremity in Subacute and Chronic Stroke

NCT03559829

COMPLETED Phase 2

[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer

NCT02695628

COMPLETED NA

Enhancing Treatment of Hoarding Disorder With Personalized In-Home Sorting and Decluttering Practice

NCT02843308

COMPLETED NA

Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration

NCT02569892

COMPLETED

Biomarker Establishment for Superior Treatment of PTSD

NCT03343028

COMPLETED Phase 1

Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)

NCT02911597

COMPLETED NA

Fermented and Fiber-rich Food (FeFiFo) Study

NCT03275662

COMPLETED NA

Remote Monitoring of Diabetes in Young Children With Type 1 Diabetes

NCT02848261

COMPLETED NA

School Water Access, Food and Beverage Intake, and Obesity

NCT03181971

COMPLETED

Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast Cancer

NCT03050463

COMPLETED

Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia

NCT02856204

COMPLETED NA

Gait Modifications and Cutaneous Stimulation

NCT02884414

COMPLETED NA

Management of Palmar Hyperhidrosis With Hydrogel-based Iontophoresis

NCT02854540

COMPLETED Phase 4

The Effectiveness of Nasal Corticosteroids Versus Placebo in Nasal Obstruction in Patients With Nasal Septal Deviation

NCT02877485

COMPLETED Phase 3

Altitude Sickness Prevention and Efficacy of Comparative Treatments

NCT02604173

TERMINATED NA

Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections

NCT02890875

COMPLETED NA

Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated Lymphedema

NCT02734979

COMPLETED NA

Listening to Mom in the NICU: Neural, Clinical and Language Outcomes

NCT02847689

COMPLETED Phase 4

Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults

NCT02912364

COMPLETED NA

Web-based Implementation for the Science of Enhancing Resilience Study

NCT02603133

COMPLETED Early Phase 1

The Effect of Cortisol Administration on Neural Correlates of Emotion in Depression

NCT02837432

COMPLETED Phase 3

Self-administered Lidocaine Gel for Pain-control During Cervical Preparation for Dilation and Evacuation

NCT02852434

COMPLETED NA

Treatment of Disruptive Behaviors in Fragile X Syndrome

NCT03510156

COMPLETED NA

Predicting Analgesic Response to Acupuncture: A Practical Approach

NCT02890810

TERMINATED NA

EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2

NCT02877732

COMPLETED NA

Chronic Cardiovascular Risk Outpatient Management in South Asians Using Digital Health Technology

NCT03167996

COMPLETED Phase 3

Self-Administered Lidocaine Gel for Pain Management With IUD Insertion

NCT02738203

COMPLETED Phase 1

Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

NCT02805075

COMPLETED NA

Research on Anxiety and Depression: Computer-Assisted Therapy

NCT02817438

COMPLETED Early Phase 1

PET/MRI Evaluation of Cardiac Amyloid

NCT03119558

COMPLETED

Prescribed Physical Activity in Improving Sleep and Physical Performance in Patients Undergoing Stem Cell Transplant

NCT02796196

COMPLETED

Non-Invasive, Highly Specific Detection of Oxytocin in Biological Fluids

NCT03140709

COMPLETED Phase 2

Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study

NCT02960997

COMPLETED NA

B-mode Ultrasound Imaging in Detecting Early Liver Cancer

NCT02774161

COMPLETED NA

Vibrotactile Stimulation in Parkinson's Disease

NCT02933476

TERMINATED NA

Embodied Virtual Reality Therapy for Functional Neurological Symptom/ Conversion Disorder

NCT02764476

COMPLETED NA

Evaluation of the Impact of Water Access and Promotion in Parks on Beverage Intake

NCT03889561

← Previous Page 19 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.